Allarity Therapeutics Doses the First Patients With Stenoparib And Temozolomide In VA-Funded Investigator-Initiated Phase 2 Trial For Relapsed Small Cell Lung Cancer

Allarity Therapeutics, Inc. 0.00% Pre

Allarity Therapeutics, Inc.

ALLR

1.19

1.19

0.00%

0.00% Pre
Allarity Therapeutics Doses the First Patients With Stenoparib And Temozolomide In VA-Funded Investigator-Initiated Phase 2 Trial For Relapsed Small Cell Lung Cancer